Janiczek Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$186K Buy
1,747
+178
+11% +$17.9K 0.04% 192
2024
Q1
$154K Buy
1,569
+183
+13% +$18.8K 0.03% 221
2023
Q4
$140K Buy
1,386
+65
+5% +$6.27K 0.03% 220
2023
Q3
$135K Buy
1,321
+115
+10% +$11.7K 0.04% 202
2023
Q2
$122K Buy
1,206
+77
+7% +$7.7K 0.03% 192
2023
Q1
$111K Sell
1,129
-104
-8% -$9.08K 0.03% 198
2022
Q4
$112K Buy
1,233
+71
+6% +$5.98K 0.03% 205
2022
Q3
$88K Sell
1,162
-911
-44% -$75.5K 0.03% 220
2022
Q2
$178K Sell
2,073
-348
-14% -$30.5K 0.05% 121
2022
Q1
$213K Buy
2,421
+888
+58% +$76.9K 0.06% 109
2021
Q4
$134K Buy
1,533
+31
+2% +$2.57K 0.04% 151
2021
Q3
$123K Buy
1,502
+145
+11% +$13K 0.04% 148
2021
Q2
$124K Buy
1,357
+69
+5% +$6.14K 0.05% 124
2021
Q1
$110K Buy
1,288
+360
+39% +$32.3K 0.04% 128
2020
Q4
$88K Buy
928
+542
+140% +$47.4K 0.04% 125
2020
Q3
$34K Buy
386
+310
+408% +$26.9K 0.02% 119
2020
Q2
$7K Buy
+76
New +$6.56K ﹤0.01% 160

Other funds holding NVS

Janiczek Wealth Management's NVS Position: Q2 2024 in Review

Janiczek Wealth Management increased its Novartis (NVS) stake by 11% in Q2 2024, buying an estimated $17.9K and bringing the position to 1,747 shares worth $186K. The position accounts for 0.04% of the portfolio, ranked #192.

Janiczek Wealth Management first reported a position in NVS in Q2 2020 and has held it in 17 quarters since. The position peaked at $213K in Q1 2022. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

  • Janiczek Wealth Management held 1,747 shares of Novartis worth $186K as of Q2 2024.
  • Janiczek Wealth Management bought 178 Novartis shares in Q2 2024, an estimated $17.9K.
  • Novartis made up 0.04% of Janiczek Wealth Management's portfolio in Q2 2024, its #192 holding.
  • Janiczek Wealth Management first reported a position in Novartis in Q2 2020 and has held it in 17 quarters since.
  • Janiczek Wealth Management's Novartis position peaked at $213K in Q1 2022.
  • 1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.